| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1178 | 17 | 887 | 104 | 1266 | 216 | 1315 |
| ERLYTX | 81 | 1 | 52 | 7 | 85 | 18 | 110 |
| GI | 182 | 3 | 157 | 18 | 219 | 31 | 189 |
| GU | 355 | 5 | 261 | 31 | 377 | 49 | 298 |
| LEUK | 151 | 2 | 104 | 15 | 183 | 32 | 195 |
| LUNG | 195 | 6 | 313 | 16 | 195 | 29 | 177 |
| LYMPH | 415 | 10 | 522 | 51 | 621 | 97 | 590 |
| MELAN | 116 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 115 | 2 | 104 | 11 | 134 | 26 | 158 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 42 | 2 | 104 | 3 | 37 | 13 | 79 |
| OTHER | 54 | 0 | 0 | 3 | 37 | 10 | 61 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2886 | 48 | 2504 | 260 | 3166 | 522 | 3178 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| CCD | 161 | 3 | 157 | 19 | 231 | 38 | 231 |
| ERLYTX | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 625 | 8 | 417 | 49 | 597 | 106 | 645 |
| LUNG | 370 | 6 | 313 | 30 | 365 | 58 | 353 |
| OTHER | 33 | 0 | 0 | 1 | 12 | 3 | 18 |
| PEOLC | 108 | 1 | 52 | 2 | 24 | 3 | 18 |
| PREV | 227 | 3 | 157 | 20 | 244 | 45 | 274 |
| SXQOL | 618 | 11 | 574 | 64 | 779 | 120 | 731 |
| Total | 2155 | 32 | 1670 | 187 | 2276 | 378 | 2300 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| BREAST | 1178 | 17 | 887 | 104 | 1266 | 216 | 1315 |
| CCD | 161 | 3 | 157 | 19 | 231 | 38 | 231 |
| ERLYTX | 89 | 1 | 52 | 7 | 85 | 19 | 116 |
| GI | 182 | 3 | 157 | 18 | 219 | 31 | 189 |
| GU | 358 | 5 | 261 | 31 | 377 | 51 | 310 |
| LEUK | 776 | 10 | 522 | 64 | 779 | 138 | 840 |
| LUNG | 565 | 12 | 626 | 46 | 560 | 87 | 530 |
| LYMPH | 415 | 10 | 522 | 51 | 621 | 97 | 590 |
| MELAN | 116 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 115 | 2 | 104 | 11 | 134 | 26 | 158 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 42 | 2 | 104 | 3 | 37 | 13 | 79 |
| OTHER | 87 | 0 | 0 | 4 | 49 | 13 | 79 |
| PEOLC | 108 | 1 | 52 | 2 | 24 | 3 | 18 |
| PREV | 227 | 3 | 157 | 20 | 244 | 45 | 274 |
| SXQOL | 619 | 11 | 574 | 64 | 779 | 120 | 731 |
| Total | 5041 | 80 | 4175 | 447 | 5441 | 900 | 5478 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 745 | 10 | 522 | 69 | 840 | 130 | 791 |
| ERLYTX | 49 | 0 | 0 | 5 | 61 | 14 | 85 |
| GI | 130 | 2 | 104 | 12 | 146 | 23 | 140 |
| GU | 280 | 3 | 157 | 24 | 292 | 35 | 213 |
| LEUK | 95 | 1 | 52 | 8 | 97 | 18 | 110 |
| LUNG | 125 | 5 | 261 | 14 | 170 | 21 | 128 |
| LYMPH | 275 | 7 | 365 | 36 | 438 | 60 | 365 |
| MELAN | 78 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 67 | 1 | 52 | 3 | 37 | 12 | 73 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 16 | 1 | 52 | 1 | 12 | 5 | 30 |
| OTHER | 54 | 0 | 0 | 3 | 37 | 10 | 61 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1916 | 30 | 1565 | 176 | 2142 | 329 | 2002 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| CCD | 130 | 2 | 104 | 12 | 146 | 25 | 152 |
| ERLYTX | 8 | 0 | 0 | 0 | 0 | 1 | 6 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 273 | 6 | 313 | 20 | 244 | 45 | 274 |
| LUNG | 232 | 2 | 104 | 19 | 231 | 37 | 225 |
| OTHER | 33 | 0 | 0 | 1 | 12 | 3 | 18 |
| PEOLC | 79 | 1 | 52 | 2 | 24 | 3 | 18 |
| PREV | 227 | 3 | 157 | 20 | 244 | 45 | 274 |
| SXQOL | 444 | 7 | 365 | 48 | 584 | 86 | 524 |
| Total | 1431 | 21 | 1095 | 124 | 1509 | 249 | 1515 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1 | 12 | 1 | 6 | |
| BREAST | 919 | 12 | 626 | 83 | 1011 | 156 | 950 |
| CCD | 160 | 3 | 157 | 17 | 207 | 30 | 183 |
| ERLYTX | 57 | 0 | 0 | 5 | 61 | 15 | 91 |
| GI | 134 | 2 | 104 | 11 | 134 | 24 | 146 |
| GU | 312 | 1 | 52 | 25 | 304 | 41 | 250 |
| LEUK | 369 | 7 | 365 | 28 | 341 | 63 | 384 |
| LUNG | 375 | 5 | 261 | 33 | 402 | 66 | 402 |
| LYMPH | 275 | 7 | 365 | 36 | 438 | 60 | 365 |
| MELAN | 78 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 67 | 1 | 52 | 3 | 37 | 12 | 73 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 40 | 1 | 52 | 4 | 49 | 6 | 37 |
| OTHER | 208 | 0 | 0 | 4 | 49 | 15 | 91 |
| PEOLC | 76 | 0 | 0 | 2 | 24 | 3 | 18 |
| PREV | 227 | 3 | 157 | 20 | 244 | 45 | 274 |
| SXQOL | 445 | 7 | 365 | 48 | 584 | 86 | 524 |
| Total | 3744 | 49 | 2556 | 321 | 3909 | 624 | 3800 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 984 | 15 | 783 | 87 | 1059 | 188 | 1144 |
| ERLYTX | 76 | 1 | 52 | 7 | 85 | 17 | 103 |
| GI | 108 | 3 | 157 | 12 | 146 | 18 | 110 |
| GU | 237 | 4 | 209 | 25 | 304 | 42 | 256 |
| LEUK | 117 | 1 | 52 | 13 | 158 | 27 | 164 |
| LUNG | 165 | 5 | 261 | 13 | 158 | 26 | 158 |
| LYMPH | 347 | 9 | 470 | 46 | 560 | 87 | 530 |
| MMYEL | 100 | 2 | 104 | 9 | 110 | 22 | 134 |
| MULT | 42 | 2 | 104 | 3 | 37 | 13 | 79 |
| Total | 2176 | 42 | 2192 | 215 | 2617 | 440 | 2678 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1972 | 25 | 1304 | 161 | 1960 | 330 | 2009 |
| AFFIL | 137 | 2 | 104 | 17 | 207 | 25 | 152 |
| CCOP/NCORP | 1238 | 24 | 1252 | 122 | 1485 | 223 | 1358 |
| Non-SWOG | 1692 | 27 | 1409 | 145 | 1765 | 320 | 1948 |
| Total | 5039 | 78 | 4069 | 445 | 5417 | 898 | 5467 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| ERLYTX | SN2426 | cSCC, IC Met/Inop, Amivantamab v Cetuximab | 1 | T | 22-MAY-26 |
| SXQOL | ACCL1931 | Leuk, All Stg, Levocarnitine Prophylaxis | 1 | E | 22-MAY-26 |
| SXQOL | ACCL1931 | Leuk, All Stg, Levocarnitine Prophylaxis | 2 | E | 22-MAY-26 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | E | 13-MAY-26 |
| LUNG | S1933 | NSCLC, Stg II-III, RT + Atezo | 2 | N | 01-MAY-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 12 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 10 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 8 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 6 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 4 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 4 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |